Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Antimicrob Agents Chemother ; 57(3): 1385-93, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23295921

RESUMEN

Recent evidence indicates that immunomodulation by antibiotics may enhance their clinical efficacy. Specifically, drug-induced leukocyte apoptosis and macrophage efferocytosis have been shown to promote the resolution of inflammation in a variety of disease settings. Tulathromycin is a new macrolide antibiotic for the treatment of bovine respiratory disease. The direct antimicrobial effects of the drug alone do not fully justify its superior clinical efficacy, and we hypothesize that tulathromycin may have immunomodulating properties. We recently reported that tulathromycin promotes apoptosis and inhibits proinflammatory NF-κB signaling in bovine neutrophils. In this study, we investigated the direct and indirect anti-inflammatory effects of tulathromycin in bovine macrophages. The findings indicate that bovine monocyte-derived macrophages and alveolar macrophages readily phagocytose tulathromycin-induced apoptotic neutrophils both in vitro and in the airways of Mannheimia haemolytica-infected calves. Moreover, tulathromycin promotes delayed, concentration-dependent apoptosis, but not necrosis, in bovine macrophages in vitro. Activation of caspase-3 and detection of mono- and oligonucleosomes in bovine monocyte-derived macrophages treated with tulathromycin was observed 12 h posttreatment; pretreatment with a pan-caspase inhibitor (ZVAD) blocked the proapoptotic effects of the drug. Lastly, tulathromycin inhibited the secretion of proinflammatory CXCL-8 in lipopolysaccharide (LPS)-stimulated bovine macrophages; this effect was independent of caspase activation or programmed cell death. Taken together, these immunomodulating effects observed in bovine macrophages help further elucidate the mechanisms through which tulathromycin confers anti-inflammatory and proresolution benefits. Furthermore, these findings offer novel insights on how antibiotics may offer anti-inflammatory benefits by modulating macrophage-mediated events that play a key role in inflammation.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Apoptosis/efectos de los fármacos , Disacáridos/farmacología , Compuestos Heterocíclicos/farmacología , Factores Inmunológicos/farmacología , Interleucina-8/antagonistas & inhibidores , Macrófagos Alveolares/efectos de los fármacos , Fagocitosis/efectos de los fármacos , Neumonía Enzoótica de los Becerros/tratamiento farmacológico , Animales , Apoptosis/inmunología , Caspasa 3/genética , Caspasa 3/metabolismo , Bovinos , Células Cultivadas , Inhibidores de Cisteína Proteinasa/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Inflamación/inmunología , Inflamación/prevención & control , Interleucina-8/biosíntesis , Interleucina-8/inmunología , Lipopolisacáridos/farmacología , Macrófagos Alveolares/inmunología , Macrófagos Alveolares/microbiología , Masculino , Mannheimia haemolytica/efectos de los fármacos , Mannheimia haemolytica/crecimiento & desarrollo , Neutrófilos/efectos de los fármacos , Neutrófilos/inmunología , Neutrófilos/microbiología , Oligopéptidos/farmacología , Neumonía Enzoótica de los Becerros/inmunología , Neumonía Enzoótica de los Becerros/patología , Transducción de Señal/efectos de los fármacos
2.
Proteomics ; 11(18): 3685-97, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21800424

RESUMEN

Proteomics analysis of bovine bronchoalveolar fluid (BAF) following induction of pneumonia with Mannheimia haemolytica using nanoflow liquid chromatography coupled with tandem mass spectrometry (nanoLC-MS/MS) resulted in the identification of 88 unique proteins. Proteins detected in BAF included antimicrobial peptides (AMPs), complement factors, acute-phase proteins, protease inhibitors, and proteins involved in oxidation-reduction. Notwithstanding biological variation, differences in relative protein abundance, determined using normalized peptide counts, were detected for select proteins in BAF from genuinely infected versus sham-infected animals. To demonstrate the applicability of using normalized peptide counts to assess protein expression trends, LC-MS/MS data for the acute-phase protein haptoglobin (HPT) were compared with ELISA data, and statistical evaluation of the relationship between the data revealed a strong measure of association. Differences were detected between sham- and genuinely infected animals for haptoglobin, as well as the AMPs cathelicidin-1 and cathelicidin-4, and inter-α-trypsin inhibitor heavy chain-4, a fairly novel protein involved in the acute phase response. Though the small sample size limited the scope of the inferences, the results indicate the likely importance of AMPs and acute-phase proteins during respiratory infection, and provide additional information regarding potential mechanisms involved in the bovine mucosal barrier defense.


Asunto(s)
Líquido del Lavado Bronquioalveolar/química , Bovinos/metabolismo , Mannheimia haemolytica/patogenicidad , Proteoma/análisis , Animales , Líquido del Lavado Bronquioalveolar/inmunología , Líquido del Lavado Bronquioalveolar/microbiología , Catelicidinas/análisis , Bovinos/microbiología , Enfermedades de los Bovinos/inmunología , Enfermedades de los Bovinos/microbiología , Cromatografía Liquida , Ensayo de Inmunoadsorción Enzimática , Haptoglobinas/análisis , Masculino , Mannheimia haemolytica/inmunología , Fragmentos de Péptidos/análisis , Neumonía Enzoótica de los Becerros/inmunología , Neumonía Enzoótica de los Becerros/microbiología , Proteómica , Espectrometría de Masas en Tándem
3.
Biom J ; 49(6): 952-63, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17722202

RESUMEN

This paper examines exact one-sided confidence limits for the risk ratio in a 2 x 2 table with structural zero. Starting with four approximate lower and upper limits, we adjust each using the algorithm of Buehler (1957) to arrive at lower (upper) limits that have exact coverage properties and are as large (small) as possible subject to coverage, as well as an ordering, constraint. Different Buehler limits are compared by their mean size, since all are exact in their coverage. Buehler limits based on the signed root likelihood ratio statistic are found to have the best performance and recommended for practical use.


Asunto(s)
Algoritmos , Intervalos de Confianza , Interpretación Estadística de Datos , Oportunidad Relativa , Animales , Bovinos , Enfermedades de los Bovinos/inmunología , Enfermedades de los Bovinos/microbiología , Hipersensibilidad a las Drogas/diagnóstico , Humanos , Análisis Numérico Asistido por Computador , Neumonía Enzoótica de los Becerros/inmunología , Neumonía Enzoótica de los Becerros/microbiología , Tuberculosis/diagnóstico
4.
Vet Immunol Immunopathol ; 111(3-4): 301-7, 2006 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-16386312

RESUMEN

The dynamics and duration of maternally derived antibodies as well as the onset of acquired immunity against Mannheimia haemolytica and Pasteurella multocida in range-pastured beef calves were investigated. Two groups of unvaccinated cattle were used in this study. Serum antibody responses were measured by enzyme-linked immunoassay for antibodies of the IgG1, IgG2 and IgM isotypes binding M. haemolytica whole cells (WC) or leukotoxin (LKT) and P. multocida outer membrane proteins (OMPs). Comparisons of mean antibody responses to M. haemolytica LKT and WC and P. multocida OMPs were made within each group. Maternally derived antibodies against M. haemolytica and P. multocida reached lowest levels at 30-90 days after birth. Calves began production of antibodies against M. haemolytica and P. multocida between 60 and 90 days of age in both groups. Based on the results of this study, in beef herds vaccinated against M. haemolytica and/or P. multocida, it may be best to vaccinate calves around 3 months of age. In contrast, beef calves from unvaccinated herds might benefit from vaccination at 4 months of age.


Asunto(s)
Enfermedades de los Bovinos/inmunología , Enfermedades de los Bovinos/microbiología , Mannheimia haemolytica/inmunología , Pasteurella multocida/inmunología , Pasteurelosis Neumónica/inmunología , Neumonía Enzoótica de los Becerros/inmunología , Animales , Anticuerpos Antibacterianos/sangre , Proteínas de la Membrana Bacteriana Externa/inmunología , Bovinos , Ensayo de Inmunoadsorción Enzimática/veterinaria , Exotoxinas/inmunología , Femenino , Inmunidad Materno-Adquirida/inmunología , Estudios Longitudinales , Pasteurelosis Neumónica/microbiología , Neumonía Enzoótica de los Becerros/microbiología
5.
Can J Vet Res ; 79(2): 81-6, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25852222

RESUMEN

Mannheimia haemolytica is an important cause of pneumonia in feedlot cattle. Nuclear factor erythroid-2-related factor 2 (Nrf2) is a redox-sensitive transcription factor responsible for the induction of antioxidant enzymes, such as heme oxygenase 1 (HO-1), within the lung. The expression of Nrf2 and HO-1 was immunohistochemically evaluated in 4 calves 24 h after experimental infection with M. haemolytica. Calves receiving normal saline served as controls. In the infected lungs, cytoplasmic Nrf2 expression was high in macrophages and bronchioles and low in alveolar epithelium, whereas nuclear expression was high in endothelial cells, macrophages, and bronchioles and lowest in alveolar epithelium. Normal lung samples displayed only faint Nrf2 cytoplasmic staining within bronchiolar epithelium. Expression of HO-1 was detected within the cytoplasm of macrophages and bronchiolar epithelial cells in all infected lung samples, whereas normal lungs displayed only weak cytoplasmic staining in bronchiolar epithelial cells. These findings suggest that bronchiolar epithelial cells and macrophages up-regulate Nrf2 expression early in the course of infection, which results in increased expression of HO-1 within these cells.


Mannheimia haemolytica est une cause importante de pneumonie chez les bovins en parc d'engraissement. Le facteur érythroïde-2 nucléaire apparenté au facteur 2 (Nrf2) est un facteur transcriptionnel sensible au potentiel redox responsable de l'induction d'enzymes antioxidants, tel que l'hème oxygénase 1 (HO-1), dans le poumon. L'expression de Nrf2 et HO-1 fut évaluée par épreuve immunohistochimique chez quatre veaux 24 h après une infection expérimentale avec M. haemolytica. Les veaux témoins ont reçu de la saline. Dans les poumons infectés, l'expression cytoplasmique de Nrf2 était élevée dans les macrophages et les bronchioles et faible dans l'épithélium alvéolaire, alors que l'expression nucléaire était élevée dans les cellules endothéliales, macrophages et bronchioles, et à son plus faible dans l'épithélium alvéolaire. Les échantillons de poumons normaux montraient seulement une faible coloration cytoplasmique pour Nrf2 dans l'épithélium des bronchioles. L'expression de HO-1 fut détectée dans le cytoplasme des macrophages et des cellules épithéliales des bronchioles de tous les échantillons de poumons infectés, alors que les échantillons de poumons normaux ne montraient qu'une faible coloration cytoplasmique dans les cellules épithéliales des bronchioles. Ces données suggèrent que les cellules épithéliales des bronchioles et les macrophages régulent à la hausse l'expression de Nrf2 tôt lors de l'infection, ce qui résulte en une expression augmentée d'HO-1 à l'intérieur de ces cellules.(Traduit par Docteur Serge Messier).


Asunto(s)
Hemo-Oxigenasa 1/metabolismo , Pulmón/metabolismo , Mannheimia haemolytica/aislamiento & purificación , Factor 2 Relacionado con NF-E2/metabolismo , Neumonía Enzoótica de los Becerros/microbiología , Animales , Bovinos , Células Epiteliales/metabolismo , Regulación de la Expresión Génica/inmunología , Hemo-Oxigenasa 1/genética , Inmunohistoquímica/veterinaria , Pulmón/enzimología , Macrófagos Alveolares/metabolismo , Factor 2 Relacionado con NF-E2/genética , Neumonía Enzoótica de los Becerros/inmunología
6.
Res Vet Sci ; 97(1): 32-7, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24815344

RESUMEN

The effect of vaccinating pregnant cows with an inactivated vaccine against Mannheimia haemolytica, BRSV and PI3V infections on selected immune responses in their offspring was examined. Blood samples were collected weekly for 12 weeks from six newborn calves from each of vaccinated (experimental) and unvaccinated (control) dams. Specific antibodies to M. haemolytica, BRSV and PI3V and mean values of IgA, IgG concentrations were significantly higher in the experimental calves compared with the controls. However, specific antibody titres to adenovirus type 3, BHV1 and BVDV in the experimental calves had constant levels while the control group levels changed. The IgM, Hp and SAA concentrations generally increased until week 8 in the experimental group, but the control group titres became higher after week 9. This study demonstrates that specific immunisation of cows pre-partum significantly stimulated parameters associated with immunity and it also controlled the acute phase response intensity in their offspring. Therefore the vaccination of dams may provide additional antibody protection against infection to their offspring.


Asunto(s)
Animales Recién Nacidos/inmunología , Vacunas Bacterianas/farmacología , Enfermedades de los Bovinos/prevención & control , Inmunidad Humoral/efectos de los fármacos , Neumonía Enzoótica de los Becerros/prevención & control , Preñez/inmunología , Vacunación/veterinaria , Animales , Anticuerpos Antibacterianos/sangre , Anticuerpos Antibacterianos/inmunología , Antígenos Bacterianos/farmacología , Antígenos Bacterianos/uso terapéutico , Vacunas Bacterianas/uso terapéutico , Bovinos , Enfermedades de los Bovinos/inmunología , Femenino , Inmunidad Humoral/inmunología , Inmunización Pasiva/veterinaria , Mannheimia haemolytica/inmunología , Neumonía Enzoótica de los Becerros/inmunología , Embarazo , Resultado del Tratamiento , Vacunas de Productos Inactivados/farmacología , Vacunas de Productos Inactivados/uso terapéutico
7.
J Vet Med Sci ; 75(12): 1675-7, 2013 Dec 30.
Artículo en Inglés | MEDLINE | ID: mdl-23965848

RESUMEN

We investigated the dynamics and duration of antibody titer against Mannheimia haemolytica in Japanese Black calves. Twenty unvaccinated calves from two Japanese Black breeding farms in Kagoshima Prefecture, Japan, were studied. The antibody titer against M. haemolytica reached the lowest level at 8 weeks of age after birth. Calves began producing antibody against M. haemolytica by themselves between 8 and 12 weeks of age. The results of this study might help designing a vaccination program against M. haemolytica for Japanese Black calves.


Asunto(s)
Anticuerpos Antibacterianos/inmunología , Enfermedades de los Bovinos/inmunología , Enfermedades de los Bovinos/microbiología , Inmunidad Materno-Adquirida/inmunología , Mannheimia haemolytica/inmunología , Neumonía Enzoótica de los Becerros/inmunología , Factores de Edad , Animales , Anticuerpos Antibacterianos/sangre , Bovinos , Enfermedades de los Bovinos/sangre , Ensayo de Inmunoadsorción Enzimática/veterinaria , Japón , Neumonía Enzoótica de los Becerros/sangre , Vacunación/métodos , Vacunación/veterinaria
8.
Anim Health Res Rev ; 10(2): 141-3, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20003650

RESUMEN

Bovine respiratory disease (BRD) involves complex interactions amongst viral and bacterial pathogens that can lead to intense pulmonary inflammation (fibrinous pleuropneumonia). Viral infection greatly increases the susceptibility of cattle to secondary infection of the lung with bacterial pathogens like Mannheimia haemolytica and Histophilus somni. The underlying reason for this viral/bacterial synergism, and the manner in which cattle respond to the virulence strategies of the bacterial pathogens, is incompletely understood. Bovine herpesvirus type 1 (BHV-1) infection of bronchial epithelial cells in vitro enhances the binding of M. haemolytica and triggers release of inflammatory mediators that attract and enhance binding of neutrophils. An exotoxin (leukotoxin) released from M. haemolytica further stimulates release of inflammatory mediators and causes leukocyte death. Cattle infected with H. somni frequently display vasculitis. Exposure of bovine endothelial cells to H. somnii or its lipooligosaccharide (LOS) increases endothelium permeability, and makes the surface of the endothelial cells pro-coagulant. These processes are amplified in the presence of platelets. The above findings demonstrate that bovine respiratory pathogens (BHV-1, M. haemolytica and H. somni) interact with leukocytes and other cells (epithelial and endothelial cells) leading to the inflammation that characterizes BRD.


Asunto(s)
Complejo Respiratorio Bovino/inmunología , Animales , Complejo Respiratorio Bovino/microbiología , Complejo Respiratorio Bovino/virología , Bovinos/inmunología , Interacciones Huésped-Patógeno/inmunología , Inmunidad Celular , Mannheimia haemolytica/inmunología , Infecciones por Pasteurella/veterinaria , Pasteurellaceae , Neumonía Enzoótica de los Becerros/inmunología
9.
Vaccine ; 27(11): 1771-6, 2009 Mar 10.
Artículo en Inglés | MEDLINE | ID: mdl-18834912

RESUMEN

UNLABELLED: We developed several chimeric PlpE-leukotoxin (LKT) constructs containing the major epitope of Mannheimia haemolytica outer membrane lipoprotein PlpE (epitope R2) and the neutralizing epitope of M. haemolytica LKT (NLKT) [Ayalew et al. Mannheimia haemolytica chimeric protein vaccine composed of the major surface-exposed epitope of outer membrane lipoprotein PlpE and the neutralizing epitope of leukotoxin. Vaccine 2008;26(38):4955-61]. Vaccination of mice with these PlpE-LKT chimeric proteins stimulated anti-PlpE antibodies that caused complement-mediated bacteriolysis of M. haemolytica as well as neutralizing anti-LKT antibodies. Chimeric protein SAC89, which contains two copies of R2 and two copies of NLKT, generally stimulated the best overall responses in mice. The objectives of the current study were: (1) to determine through a dose titration study if vaccination of cattle with SAC89 stimulated antibodies to both PlpE and LKT and (2) evaluate SAC89-induced immunity against experimental M. haemolytica challenge of cattle. In the dose titration study, vaccine doses ranged from 100 to 400 microg. SAC89 significant anti-M. haemolytica surface and LKT antibodies were detected following vaccination with each dose. The vaccination/challenge study was conducted with 30 weaned beef cattle distributed among four groups: Control (no vaccine), 100 microg SAC89, M. haemolytica Bacterin, and SAC89+M. haemolytica bacterin. On day 42 after two vaccinations, cattle were challenged transthoracically with M. haemolytica. There was significant reduction (p<0.05) in lesion scores for the SAC89+bacterin-vaccinated group (74.6% reduction compared to control lesion scores) when compared to the other groups (34.7% and 35.6% reduction compared to control lesion scores). Evaluation of antibody responses demonstrated that the control group failed to develop antibody responses to M. haemolytica surface antigens or to LKT. Bacterin-vaccinated cattle developed anti-M. haemolytica antibodies after the second vaccination. SAC89- and SAC89+bacterin-vaccinated groups developed significant antibody responses 14 days after the first vaccination and further significant increases in antibodies after the second vaccination. CONCLUSIONS: Vaccination with the chimeric protein SAC89 in conjunction with a M. haemolytica bacterin stimulated significant protection against a severe transthoracic challenge with the bacterium.


Asunto(s)
Proteínas de la Membrana Bacteriana Externa/inmunología , Vacunas Bacterianas/inmunología , Lipoproteínas/inmunología , Mannheimia haemolytica/inmunología , Neumonía Enzoótica de los Becerros/inmunología , Secuencia de Aminoácidos , Animales , Anticuerpos Antibacterianos/análisis , Anticuerpos Antibacterianos/biosíntesis , Vacunas Bacterianas/efectos adversos , Temperatura Corporal/fisiología , Bovinos , Ensayo de Inmunoadsorción Enzimática , Epítopos/genética , Epítopos/inmunología , Datos de Secuencia Molecular , Proteínas Mutantes Quiméricas/inmunología , Neumonía Enzoótica de los Becerros/prevención & control , Vacunación
10.
J Anim Sci ; 85(7): 1770-9, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17371793

RESUMEN

Previous research from our laboratory has indicated that melengestrol acetate (MGA) added to the diet during the first 35 d after arrival in the feedlot improves growth rates and tends to reduce chronic respiratory disease in heifers naturally challenged with bovine respiratory disease. The current study was conducted to provide further insight into the possible immunomodulatory effects of MGA. Crossbred heifers (n = 48; 232 +/- 5.5 kg of BW) were used in a randomized complete block design to determine the effects of MGA on lung pathology and markers of inflammation after Mannheimia haemolytica challenge. On d 0, cattle were blocked by BW and randomly assigned, within block, to diets (54% concentrate) that provided 0 or 0.5 mg of MGA per heifer daily for the duration of the experiment. Inoculum containing from 1.3 x 10(9) to 1.7 x 10(9) cfu of M. haemolytica (20 mL) was instilled at the bifurcation of the trachea on d 14. Blood samples were collected, clinical observations were made, and rectal temperatures were recorded for each animal at 0, 12, 24, 48, 72, 96, 120, and 138 h after inoculation. Heifers fed MGA had greater circulating concentrations of eosinophils and postchallenge concentrations of segmented neutrophils and white blood cells (P < 0.01) than controls, as well as elevated plasma protein, serum haptoglobin, and fibrinogen after M. haemolytica challenge (P < 0.01). Heifers fed MGA had lower plasma glucose (P < 0.01), greater plasma urea N (P = 0.02), and elevated respiratory indices (P < 0.01) compared with controls. Necropsies performed on d 6 after inoculation suggested that M. haemolytica challenge was relatively mild, because lesions were confined to a small portion of the lungs. On a 0 to 100 scale, average lung lesion scores were 3 and 1 for MGA-fed and control groups, respectively (P < 0.06). Heifers fed MGA before mild M. haemolytica challenge were more susceptible to infection, as evidenced by a greater number of heifers fed MGA exhibiting pulmonary lesions 138 h after inoculation than controls (14 out of 23 vs. 6 out of 24 for MGA and controls, respectively; P < 0.02).


Asunto(s)
Pulmón/patología , Mannheimia haemolytica/patogenicidad , Acetato de Melengestrol/farmacología , Neumonía Enzoótica de los Becerros/patología , Proteínas de Fase Aguda/análisis , Animales , Glucemia/análisis , Nitrógeno de la Urea Sanguínea , Bovinos , Recuento de Colonia Microbiana/veterinaria , Relación Dosis-Respuesta a Droga , Femenino , Fibrinógeno/análisis , Haptoglobinas/análisis , Pulmón/inmunología , Pulmón/microbiología , Neumonía Enzoótica de los Becerros/sangre , Neumonía Enzoótica de los Becerros/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA